Marjon H. Cnossen

4.4k citations

178 papers · 2.6k indexed · h-index 30

Hematology top 0.5%
Genetics top 1%
Neurology top 5%
Surgery
Epidemiology top 10%

Co-authors: Frank W.G. Leebeek Karin Fijnvandraat Karina Meijer Ron A. A. Mathôt Johanna G. van der Bom Britta A. P. Laros‐van Gorkom Jeroen Eikenboom Marjolein Peters
Topics: Hemophilia Treatment and Research (93 papers)Platelet Disorders and Treatments (87 papers)Blood Coagulation and Thrombosis Mechanisms (33 papers)
Cited by: Hematology Genetics Internal Medicine
Journals: SHILAP Revista de lepidopterologíaBlood PLoS ONE
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Marjon H. Cnossen

164 papers receiving 2.5k citations

Peers

Countries citing papers authored by Marjon H. Cnossen

Since Specialization

Citations

This map shows the geographic impact of Marjon H. Cnossen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjon H. Cnossen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjon H. Cnossen more than expected).

Fields of papers citing papers by Marjon H. Cnossen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjon H. Cnossen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjon H. Cnossen. The network helps show where Marjon H. Cnossen may publish in the future.

Co-authorship network of co-authors of Marjon H. Cnossen

This figure shows the co-authorship network connecting the top 25 collaborators of Marjon H. Cnossen. A scholar is included among the top collaborators of Marjon H. Cnossen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjon H. Cnossen. Marjon H. Cnossen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National Survey 2025 ·Haemophilia ·(unknown),(unknown),(unknown),Yvonne Henskens,Maartje van den Biggelaar,Roger E. G. Schutgens,Saskia E.M. Schols,(unknown),Karina Meijer,Paul L. den Exter,Laurens Nieuwenhuizen,(unknown),Marieke J. H. A. Kruip,Marjon H. Cnossen,Floor Heubel-Moenen,(unknown)	0
2	Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands study 2025 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Marjon H. Cnossen,Nick van Es,Paul L. den Exter,(unknown),Karina Meijer,Laurens Nieuwenhuizen,(unknown),Nicole M. A. Blijlevens,Waander L. van Heerde,Saskia E.M. Schols	0
3	PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown),Erik Sjögren,(unknown),Peter J. Lenting,Marjon H. Cnossen,Ron A. A. Mathôt	1
4	Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients 2024 ·Haemophilia ·(unknown),(unknown),Reinier M. van Hest,Karina Meijer,Britta A. P. Laros‐van Gorkom,Laurens Nieuwenhuizen,Jeroen Eikenboom,Floor Heubel-Moenen,(unknown),Michiel Coppens,Karin Fijnvandraat,M.H.E. Driessens,Suzanne Polinder,Marjon H. Cnossen,Frank W.G. Leebeek,Ron A. A. Mathôt,Marieke J. H. A. Kruip	0
5	Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study 2024 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Annet Simons,(unknown),Marjan M. Weiss,Sanna R. Rijpma,(unknown),Karina Meijer,Marjon H. Cnossen,Roger E. G. Schutgens,Nick van Es,Laurens Nieuwenhuizen,Paul L. den Exter,(unknown),Nicole M. A. Blijlevens,Waander L. van Heerde,Saskia E.M. Schols	4
6	A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B 2023 ·British Journal of Clinical Pharmacology ·(unknown),(unknown),(unknown),(unknown),Frank W.G. Leebeek,Karin Fijnvandraat,Michiel Coppens,Mary Mathias,Peter W. Collins,Robert C. Tait,Catherine Bagot,Nicola Curry,Jeanette Payne,Pratima Chowdary,Marjon H. Cnossen,Ron A. A. Mathôt	3
7	Patient-relevant health outcomes for von Willebrand disease, platelet function disorders, and rare bleeding disorders: a Delphi study 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Hester F. Lingsma,Marjon H. Cnossen,Samantha C. Gouw	3
8	DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A 2023 ·BMJ Open ·(unknown),(unknown),Toine C. G. Egberts,Karin Fijnvandraat,Ron A. A. Mathôt,(unknown),Marjon H. Cnossen,Roger E. G. Schutgens,Rolf T. Urbanus,Kathelijn Fischer	3
9	ChatGPT in pharmacometrics? Potential opportunities and limitations 2023 ·British Journal of Clinical Pharmacology ·(unknown),Alexander Janßen,(unknown),Marjon H. Cnossen,Ron A. A. Mathôt	17
10	One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study 2023 ·Blood Advances ·(unknown),Minke A.E. Rab,Brigitte A. van Oirschot,(unknown),(unknown),Anita W. Rijneveld,Marjon H. Cnossen,Erfan Nur,Bart J. Biemond,Marije Bartels,Judith Jans,Wouter W. van Solinge,Roger E. G. Schutgens,Richard van Wijk,Eduard J. van Beers	8
11	Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study 2023 ·Haemophilia ·(unknown),(unknown),Marjon H. Cnossen,Cees Smit,Lize F. D. van Vulpen,Paul van der Valk,Jeroen Eikenboom,Floor Heubel-Moenen,(unknown),Paula F. Ypma,Laurens Nieuwenhuizen,Michiel Coppens,Saskia E.M. Schols,Britta A. P. Laros‐van Gorkom,Frank W.G. Leebeek,M.H.E. Driessens,Frits R. Rosendaal,Johanna G. van der Bom,Karin Fijnvandraat,Samantha C. Gouw	0
12	Oxygen gradient ektacytometry–derived biomarkers are associated with acute complications in sickle cell disease 2023 ·Blood Advances ·Minke A.E. Rab,(unknown),Camille Boisson,(unknown),Brigitte A. van Oirschot,Maite E. Houwing,Céline Renoux,Marije Bartels,Anita W. Rijneveld,Erfan Nur,Marjon H. Cnossen,Philippe Joly,Élie Nader,Romain Fort,Philippe Connes,Richard van Wijk,Vivien Sheehan,Eduard J. van Beers	5
13	Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease 2022 ·Blood Advances ·Ferdows Atiq,(unknown),(unknown),Johan Boender,(unknown),Waander L. van Heerde,(unknown),(unknown),(unknown),Joke de Meris,Saskia E.M. Schols,(unknown),Johanna G. van der Bom,Marjon H. Cnossen,Karina Meijer,Karin Fijnvandraat,Jeroen Eikenboom,Frank W.G. Leebeek	9
14	Joint status of patients with nonsevere hemophilia A 2022 ·Journal of Thrombosis and Haemostasis ·(unknown),(unknown),Robert Hemke,Samantha C. Gouw,Michiel Coppens,(unknown),Marieke J. H. A. Kruip,Marjon H. Cnossen,Frank W.G. Leebeek,Barbara A. Hutten,Mario Maas,Karin Fijnvandraat	23
15	Outcome of Surgical Interventions and Deliveries in Patients with Bleeding of Unknown Cause: An Observational Study 2021 ·Thrombosis and Haemostasis ·(unknown),(unknown),Lorenzo Romano,(unknown),Marjon H. Cnossen,Moniek P.M. de Maat,Frank W.G. Leebeek,Marieke J.H.A. Kruip	12
16	von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients 2020 ·Thrombosis and Haemostasis ·(unknown),(unknown),(unknown),Roger E. G. Schutgens,Britta A. P. Laros‐van Gorkom,Laurens Nieuwenhuizen,F.J.M. van der Meer,Karin Fijnvandraat,Paula F. Ypma,Moniek P.M. de Maat,Frank W.G. Leebeek,Karina Meijer,Jeroen Eikenboom,Ron A. A. Mathôt,Marjon H. Cnossen,(unknown)	5
17	Performance of factor IX extended half‐life product measurements in external quality control assessment programs 2020 ·Journal of Thrombosis and Haemostasis ·(unknown),Steve Kitchen,Piet Meijer,Marjon H. Cnossen,(unknown),Geoffrey Kershaw,Ian Jennings,Isobel D. Walker,Moniek P.M. de Maat	13
18	Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding 2020 ·Journal of Thrombosis and Haemostasis ·Ferdows Atiq,(unknown),Moniek P.M. de Maat,Marieke J. H. A. Kruip,Marjon H. Cnossen,Frank W.G. Leebeek	6
19	In Vivo T1 of Blood Measurements in Children with Sickle Cell Disease Improve Cerebral Blood Flow Quantification from Arterial Spin-Labeling MRI 2016 ·American Journal of Neuroradiology ·Lena Václavů,(unknown),Dennis Heijtel,Matthias J.P. van Osch,Marjon H. Cnossen,Charles B.L.M. Majoie,Adam Bush,John C. Wood,(unknown),Henk Mutsaerts,Aart J. Nederveen	32
20	[Von Willebrand disease in the Netherlands: the WiN study]. 2014 ·PubMed ·Yvonne Sanders,(unknown),Karina Meijer,Jeroen Eikenboom,Johanna G. van der Bom,(unknown),(unknown),Marjon H. Cnossen,Evelien P. Mauser‐Bunschoten,Frank W.G. Leebeek	4

About Marjon H. Cnossen

Marjon H. Cnossen is a scholar working on Hematology, Genetics and Internal Medicine, having authored 178 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (93 papers), Platelet Disorders and Treatments (87 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (685 citations) and Internal Medicine (106 citations). Marjon H. Cnossen has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Frank W.G. Leebeek, Karin Fijnvandraat, Karina Meijer, Ron A. A. Mathôt, Johanna G. van der Bom, Britta A. P. Laros‐van Gorkom, Jeroen Eikenboom, Marjolein Peters, Inge M. Appel and Martinus F. Niermeijer. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact